New roles for Gsk-3β and Wnts during skull vault osteogenesis

被引：0
|
作者：
Rogers, Heather L. Szabo [1 ]
Smithers, Lucy E. [1 ]
Liu, Karen J. [1 ]
机构：
[1] Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England
来源：
GENETICS RESEARCH | 2010年 / 92卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [41] Synthesis and biological evaluation of thienopyrrolizines, a new family of CDK/GSK-3 inhibitors
    Rochais, C
    Lescot, E
    Lisowski, V
    Lepailleur, A
    Santos, JSD
    Bureau, R
    Dallemagne, P
    Meijer, L
    Rault, S
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2004, 19 (06) : 585 - 593
  • [42] Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3
    Martinez de Iturrate, Paula
    Sebastian-Perez, Victor
    Nacher-Vazquez, Montserrat
    Tremper, Catherine S.
    Smirlis, Despina
    Martin, Julio
    Martinez, Ana
    Campillo, Nuria E.
    Rivas, Luis
    Gil, Carmen
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 199 - 210
  • [43] GSK-3 inhibitors: A New Class of Drugs for Alzheimer's Disease Treatment
    Pal, Dilipkumar
    Mukherjee, Souvik
    Song, In-Ho
    Nimse, Satish B.
    CURRENT DRUG TARGETS, 2021, 22 (15) : 1725 - 1737
  • [44] New Insights Into the Role of GSK-3 in the Regulation of Human Cardiac Electrophysiology COMMENT
    Forte, Maurizio
    Iacovone, Giuliano
    Sciarretta, Sebastiano
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2022, 7 (10): : 1018 - 1020
  • [45] CDK/GSK-3 inhibitors as a new approach for the treatment of proliferative renal diseases
    Soos, Timothy J.
    Meijer, Laurent
    Nelson, Peter J.
    DRUG NEWS & PERSPECTIVES, 2006, 19 (06) : 325 - 328
  • [46] Arsenic inhibits neurofilament transport and induces perikaryal accumulation of phosphorylated neurofilaments:: Roles of JNK and GSK-3β
    DeFuria, Jason
    Shea, Thomas B.
    BRAIN RESEARCH, 2007, 1181 : 74 - 82
  • [47] Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances mitochondrial biogenesis during myogenesis
    Theeuwes, W. F.
    Gosker, H. R.
    Langen, R. C. J.
    Pansters, N. A. M.
    Schols, A. M. W. J.
    Remels, A. H. V.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (09): : 2913 - 2926
  • [48] ILK inhibition reduces osteophyte formation through suppression of osteogenesis in BMSCs via Akt/GSK-3β/β-catenin pathway
    Huang, Zhixiang
    Huang, Lixin
    Ding, Jiali
    Huang, Yukai
    Huang, Xuechan
    Li, Tianwang
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [49] GSK-3β suppression upregulates Gli1 to alleviate osteogenesis inhibition in titanium nanoparticle-induced osteolysis
    Wang, Qing
    Zhang, Wei
    Peng, Xiaole
    Tao, Yunxia
    Gu, Ye
    Li, Wenming
    Liang, Xiaolong
    Wang, Liangliang
    Wu, Zerui
    Wang, Tianhao
    Zhang, Haifeng
    Liu, Xin
    Xu, Yaozeng
    Liu, Yu
    Zhou, Jun
    Geng, Dechun
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [50] GSK-3β suppression upregulates Gli1 to alleviate osteogenesis inhibition in titanium nanoparticle-induced osteolysis
    Qing Wang
    Wei Zhang
    Xiaole Peng
    Yunxia Tao
    Ye Gu
    Wenming Li
    Xiaolong Liang
    Liangliang Wang
    Zerui Wu
    Tianhao Wang
    Haifeng Zhang
    Xin Liu
    Yaozeng Xu
    Yu Liu
    Jun Zhou
    Dechun Geng
    Journal of Nanobiotechnology, 20
12345